Eritrea vs Kyrgyzstan: Number of deaths from cardiovascular diseases by type
Eritrea
113.52 deaths
in 2021
Kyrgyzstan
105.78 deaths
in 2021
Eritrea rank
94th
Kyrgyzstan rank
97th
Number of deaths from cardiovascular diseases by type over time
- Eritrea
- Kyrgyzstan
How they compare
Eritrea currently reports 113.52 deaths against 105.78 deaths in Kyrgyzstan, a difference of 7.74 deaths.
That makes Eritrea's figure about 1.1 times Kyrgyzstan's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Kyrgyzstan ahead.
Eritrea ranks 94th and Kyrgyzstan ranks 97th of 194 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 103.14 deaths | 268.52 deaths | 165.37 deaths | Kyrgyzstan |
| 2010s | 108.53 deaths | 170.33 deaths | 61.8 deaths | Kyrgyzstan |
| 2020s | 112.16 deaths | 112.34 deaths | 0.185 deaths | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases by type, Eritrea or Kyrgyzstan?
- Eritrea, at 113.52 deaths against 105.78 deaths in Kyrgyzstan as of 2021.
- What is the difference in number of deaths from cardiovascular diseases by type between Eritrea and Kyrgyzstan?
- 7.74 deaths, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Kyrgyzstan?
- 22 years are reported by both, from 2000 to 2021.
- How do Eritrea and Kyrgyzstan rank globally for number of deaths from cardiovascular diseases by type?
- Eritrea ranks 94th and Kyrgyzstan ranks 97th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from rheumatic heart disease in both sexes.